Pacific Biosciences of California PACB
Pacific Biosciences entered into a $100M sales agreement
Pacific Biosciences of California (PACB) filed an 8-K with the SEC on Nov 10, 2026, 4:08 pm ET. Source: the filing on SEC EDGAR.
Item 1.01 Enters material agreement
- Form
- 8-K
- Filed
- Importance
- Major
- Accession
- 0001104659-26-125166
- Sales agreement with Allen & Company LLC for up to $100M in shares
- Shares to be sold via at-the-market program
- Compensation for Allen up to 3% of gross proceeds
- Shares issued under automatic shelf registration (lets the company sell securities later)
Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.
